Literature DB >> 16352529

Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency.

N M Sawtell1, R L Thompson, R L Haas.   

Abstract

The herpes simplex virus genome can enter a repressed transcriptional state (latency) in sensory neurons of the host nervous system. Although reduced permissiveness of the neuronal environment is widely accepted as a causal factor, the molecular pathway(s) directing and maintaining the viral genome in the latent state remains undefined. Over the past decade, the field has been strongly influenced by the observations of Kosz-Vnenchak et al., which have been interpreted to indicate that, in sensory neurons in vivo, a critical level of viral DNA synthesis within the neuron is required for sufficient viral immediate-early (IE) and early (E) gene expression (M. Kosz-Vnenchak, J. Jacobson, D. M. Coen, and D. M. Knipe, J. Virol. 67:5383-5393, 1993). The levels of IE and E genes are, in turn, thought to regulate the decision to enter the lytic cycle or latency. We have reexamined this issue using new strategies for in situ detection and quantification of viral gene expression in whole tissues. Our results using thymidine kinase-null and rescued mutants as well as wild-type strains in conjunction with viral DNA synthesis blockers demonstrate that (i) despite inhibition of viral DNA replication, many neurons express lytic viral proteins, including IE proteins, during acute infection in the ganglion; (ii) at early times postinoculation, the number of neurons expressing viral proteins in the ganglion is not reduced by inhibition of viral DNA replication; and (iii) following a reactivation stimulus, the numbers of neurons and apparent levels of lytic viral proteins, including IE proteins, are not reduced by inhibition of viral DNA replication. We conclude that viral DNA replication in the neuron per se does not regulate IE gene expression or entry into the lytic cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16352529      PMCID: PMC1317510          DOI: 10.1128/JVI.80.1.38-50.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

2.  Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.

Authors:  N M Sawtell; R L Thompson; L R Stanberry; D I Bernstein
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

3.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.

Authors:  N M Sawtell; D I Bernstein; L R Stanberry
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

10.  Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus.

Authors:  M F Kramer; S H Chen; D M Knipe; D M Coen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more
  20 in total

1.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

2.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

3.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

5.  Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.

Authors:  Steve D Haenchen; Jeff A Utter; Adam M Bayless; Rick T Dobrowsky; David J Davido
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

6.  Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.

Authors:  Pavitra Roychoudhury; David A Swan; Elizabeth Duke; Lawrence Corey; Jia Zhu; Veronica Davé; Laura Richert Spuhler; Jennifer M Lund; Martin Prlic; Joshua T Schiffer
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.

Authors:  Senad Divanovic; Nancy M Sawtell; Aurelien Trompette; Jamie I Warning; Alexandra Dias; Andrea M Cooper; George S Yap; Moshe Arditi; Kenichi Shimada; James B Duhadaway; George C Prendergast; Randall J Basaraba; Andrew L Mellor; David H Munn; Julio Aliberti; Christopher L Karp
Journal:  J Infect Dis       Date:  2011-10-11       Impact factor: 5.226

8.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

9.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Aarthi Narayanan; Hua Peng; Thomas M Kristie
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.